Roles of neutrophil/lymphocyte ratio in prognosis and in differentiation of potential beneficiaries in HER2-positive breast cancer with trastuzumab therapy

BACKGROUND: The relationship of neutrophil/lymphocyte ratio (NLR) to prognosis of HER2-positive breast cancer (BC) is not well studied. We aimed to assess the prognostic role of NLR in HER2-positive BC patients treated with or without trastuzumab. METHODS: The clinical data of 843 HER2-positive BC p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Nianhua, Huang, Juan, Li, Ningsha, Yuan, Jiaqi, Wang, Shouman, Xiao, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082930/
https://www.ncbi.nlm.nih.gov/pubmed/32192443
http://dx.doi.org/10.1186/s12885-020-06750-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082930/
https://www.ncbi.nlm.nih.gov/pubmed/32192443
http://dx.doi.org/10.1186/s12885-020-06750-3

Ejemplares similares